Given the synergistic roles of increased complement activity and kinin/kallikrein system activation in cerebral edema, these findings suggest that gC1qR targeting should be domain-specific to mediate these distinct proinflammatory pathways implicated in AIS. Here, C1QBP is linked to androgen insensitivity syndrome.